Global Women Health Diagnostics Market Is Predicted to Augment More Actively Owing to High Prevalence of Infectious Diseases: Ken Research

Women are more susceptible to certain syndromes likewise menstrual syndrome, osteoporosis, cancer, autoimmune syndromes and sexual disorders. The foremost diseases comprise breast cancer, cervical cancer, infertility, menopause, and polycystic ovarian syndrome (PCOS). As per the centers for Disease Control and Prevention, PCOS is one of the most primary causes of female infertility, impacting 6% to 12% (as several as 5 million) of US of reproductive age.

According to the report analysis, ‘Women Health Diagnostics Market: Current Analysis and Forecast (2021-2027)’ states that the requirement for Women's Health Diagnostics is majorly increasing on account of the growing incidence of chronic and lifestyle disorders, increasing awareness regarding several health-related disorders, high prevalence of infectious diseases such as hepatitis and HIV in women all over the globe. Moreover, the growing number of diagnostic and imaging centers and the high implementation of POC diagnostic testing also influence market growth. As per the Joint United Nations Programme on HIV and AIDS 2020, women and girls registered for about 50% of all new HIV infections during 2020 while in sub-Saharan Africa, women and girls registered for 63% of all new HIV infections.

Based on End-user, the market is segmented into Diagnostics Centers, Hospitals, and Homecare. The home care segment controls the largest share during 2020 and is predicted to account the highest CAGR in the forthcoming period owing to the growing incidents of infectious diseases which has resulted in augmented use of self-testing kits. The self-testing kits enable the patients to maintain their diseases by using these kits. Furthermore, Technological advancements have made several self-testing kits available for several conditions, such as pregnancy and ovulation. For instance, the Prega News Pregnancy Kit improved by Mankind Pharmaceuticals Ltd utilizes a sera reagent that will detect Human chorionic gonadotropin (HCG) content in a woman's urine, suggesting whether a woman is pregnant or not remotely.

Not only has this, growth in geriatric female population, augment in incidence of chronic and lifestyle disorders, requirement for point of care diagnostic testing, and high implementation of diagnostics imaging procedures. Moreover, countless government initiatives to encourage the women health awareness also propels the women health diagnostics market growth. However, the market growth is restricted by high cost of diagnostics tests and dearth of skilled specialists. Conversely, surge in requirement for the development of miniature diagnostic devices, augment in healthcare infrastructure, and creative marketing initiatives by foremost vendors in underdeveloped countries are expected to deliver the lucrative opportunities for the market extension during the forecast duration.

North America will register the Women Health Diagnostics market on dominate of the growing pervasiveness of infectious diseases amongst women, growing implementation of technologically advanced products, and growing government initiatives. During 2021, Hologic, Inc., a worldwide leader in women's health, obtained Biotheranostics, Inc., a privately controlled, commercial-stage company that delivers the molecular diagnostic tests for breast and metastatic cancers, for nearly USD XX million, to strengthen its existence in the women's health diagnostics market.

For More Information, refer to below link:-

Global Women Health Diagnostics Market

Follow Us:-

LinkedIn | Instagram | Facebook | Twitter | YouTube

Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
Support@kenresearch.com
+91-9015378249